Biological activities and potential functional optimization strategies of corosolic acid: a review
Baozhu Shi , Haixin Sun , Zhuang Sun , Qiaojun Jia , Hao Zhang , Yong Mao , Zisheng Luo
Food Innovation and Advances ›› 2025, Vol. 4 ›› Issue (2) : 228 -237.
Biological activities and potential functional optimization strategies of corosolic acid: a review
Corosolic acid, a naturally occurring pentacyclic triterpenic acid, is widely recognized for its broad spectrum of biological activities, particularly its anti-diabetic properties, making it a popular ingredient in dietary supplements for regulating blood sugar levels. Beyond its anti-diabetic effects, recent studies have revealed its therapeutic potential in areas such as anti-cancer, anti-inflammatory, and antibacterial activities. However, its clinical application is hindered by poor water solubility and low bioavailability due to its molecular structure. This review systematically examines the pharmacological activities of corosolic acid, emphasizing its mechanisms of action in disease intervention. Emerging strategies to overcome its inherent limitations, including chemical modifications, microbial transformations, and advanced delivery systems, are also discussed. Notably, some chemical derivatives exhibit α-glucosidase inhibition with IC50 values half that of corosolic acid. Microbial transformations have been shown to enhance its bioavailability while reducing cancer cell toxicity. Additionally, corosolic acid-based delivery systems have demonstrated significant improvements in solubility, stability, and biological activity. By consolidating current insights into its functional properties and biological activity enhancement methods, this review aims to emphasize the practical application values in food and medicine and the future development of corosolic acid as a versatile bioactive compound.
Corosolic acid / Natural bioactive compound / Anti-diabetic properties / Anti-cancer activity / Biological activity
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
XuS,Yu W, Zhang X, Wang W, Wang X. 2022. The regulatory role of Gnao 1 protein in diabetic encephalopathy in KK-Ay mice and strepto-zotocin-induced diabetic rats. Brain Research 1792:148012 |
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
/
| 〈 |
|
〉 |